Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple brochure get more patients into clinical trials?

NCT ID NCT07343297

Knowledge-focused Sponsor: Barbara Ann Karmanos Cancer Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This study tests a brochure called ASQ-CT that helps patients ask their doctors better questions about clinical trials. About 293 adults with cancer, heart disease, or neurological conditions will use the brochure before a doctor visit. Researchers want to see if it makes patients more confident and increases trial participation.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ask Questions about Clinical Trials brochure (a question prompt list)
What this could lead to
If it works, this could give doctors and hospitals a simple tool to help more patients learn about and join clinical trials.
What could go wrong
This is an early implementation study, not a treatment trial. The brochure may not change how many people actually join trials, and results may not apply to all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 293 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2026

An estimate. Start dates often move.

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \> or equal to 18 years * Appointment to see a provider at a Karmanos Cancer Institute-McLaren or a medical encounter at McLaren Center for Research and Innovation (MCRI) site for medical/systemic treatment * Potentially eligible for a clinical trial * Speak and read English well enough to be able to understand consent documents and complete surveys Exclusion Criteria: * Not able to complete study documents on their own physically or cognitively

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart disorder neoplasm nervous system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac disease Neurologic disorder Oncology

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Karmanos Cancer Institute at McLaren Bay Region

    RECRUITING

    Bay City, Michigan, 48706, United States

  • Karmanos Cancer Institute at McLaren Central Michigan, Morey Cancer Center

    RECRUITING

    Mount Pleasant, Michigan, 48858, United States

  • Karmanos Cancer Institute at McLaren Clarkston

    RECRUITING

    Clarkston, Michigan, 48346, United States

  • Karmanos Cancer Institute at McLaren Greater Lansing

    RECRUITING

    Lansing, Michigan, 48910, United States

  • Karmanos Cancer Institute at McLaren Lapeer

    RECRUITING

    Lapeer, Michigan, 48446, United States

  • Karmanos Cancer Institute at McLaren Macomb

    RECRUITING

    Mount Clemens, Michigan, 48043, United States

  • Karmanos Cancer Institute at McLaren Northern Michigan

    RECRUITING

    Petoskey, Michigan, 49770, United States

  • Karmanos Cancer Institute at McLaren Port Huron

    RECRUITING

    Port Huron, Michigan, 48060, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.